The present analysis addressed behavioral changes after treatment with 4.5
mg/kg or 18.5 mg/kg of the GABA-uptake inhibitor tiagabine combined with ei
ther the benzodiazepine diazepam (1.5 mg/kg) or the imidazopyridine zolpide
m (0.05 mg/kg), the latter two acting differentially on GABA(A) receptor su
btypes. The study included 97 male PVG/OIaHsd rats. A standard open field,
an enriched open field, and an elevated plus-maze was used to study rat beh
avior. Treatment with the low dose of tiagabine alone induced no specific b
ehavioral effects, whereas the high dose had an anxiolytic-like potential.
Furthermore, diazepam but not zolpidem displayed anxiolytic-like effects. C
ombination of each benzodiazepine receptor agonist with tiagabine at the lo
w dose decreased explorative activity. Diazepam plus the high dose of tiaga
bine increased the activity in the open-field test. Zolpidem together with
18.5 mg/kg tiagabine had an angiogenic-like effect compared to pure tiagabi
ne treatment. These results provide evidence for a pharmacodynamic interact
ion between the GABA-uptake inhibitor tiagabine and diazepam or zolpidem. T
he interaction might be relevant in the clinic when combining the anticonvu
lsant tiagabine and a benzodiazepine receptor agonist. (C) 2000 Elsevier Sc
ience Inc.